Details of the Drug Reposition

General Information of This Drug (ID: DMJ2Y1C)

Drug Name
CAP-1002   DMJ2Y1C

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Duchenne dystrophy DISHFA7H 8C70 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myocardial infarction DIS655KI BA41-BA43 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03406780) A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-2). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02485938) HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne).